We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$603M
2
CHTR icon
Charter Communications
CHTR
+$504M
3
FIS icon
Fidelity National Information Services
FIS
+$496M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$429M
5
BAX icon
Baxter International
BAX
+$362M

Sector Composition

Rank Sector Weight
1 Healthcare 3.54%
2 Technology 3.36%
3 Financials 2.95%
4 Consumer Discretionary 2.92%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELS icon
6826
CALL
Equity Lifestyle Properties
ELS
$12.7B
$519K ﹤0.01%
8,300
-800
-9% -$49.1K
ESNT icon
6827
CALL
Essent Group
ESNT
$6.25B
$519K ﹤0.01%
14,300
-20,800
-59% -$638K
GTLS
6828
PUT
DELISTED
Chart Industries
GTLS
$519K ﹤0.01%
10,700
-3,600
-25% -$132K
LOVE
6829
PUT
LoveSac
LOVE
$253M
$519K ﹤0.01%
19,800
-400
-2% -$6.08K
RGNX icon
6830
PUT
Regenxbio
RGNX
$711M
$519K ﹤0.01%
14,100
-20,600
-59% -$768K
PRVB
6831
PUT
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$519K ﹤0.01%
36,800
+23,200
+171% +$293K
BYSI icon
6832
BeyondSpring
BYSI
$34.5M
$518K ﹤0.01%
+34,342
New +$524K
ARLP icon
6833
PUT
Alliance Resource Partners
ARLP
$3.27B
$517K ﹤0.01%
158,500
+41,800
+36% +$143K
FCEF icon
6834
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.7M
$517K ﹤0.01%
+27,494
New +$494K
MOV icon
6835
Movado Group
MOV
$803M
$517K ﹤0.01%
47,734
-10,303
-18% -$111K
GRTS
6836
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$517K ﹤0.01%
77,750
-23,070
-23% -$155K
AVT icon
6837
PUT
Avnet
AVT
$7.86B
$516K ﹤0.01%
18,500
-21,300
-54% -$591K
NVMI
6838
PUT
Nova
NVMI
$13.3B
$516K ﹤0.01%
+10,700
New +$455K
RDY icon
6839
Dr. Reddy's Laboratories
RDY
$10.2B
$516K ﹤0.01%
48,675
+15,360
+46% +$156K
PGEN icon
6840
PUT
Precigen
PGEN
$2.18B
$515K ﹤0.01%
103,300
-9,800
-9% -$33.3K
WSO icon
6841
CALL
Watsco Inc
WSO
$12.9B
$515K ﹤0.01%
2,900
-6,100
-68% -$1.01M
SRCL
6842
PUT
DELISTED
Stericycle Inc
SRCL
$515K ﹤0.01%
9,200
-9,100
-50% -$474K
ATRA icon
6843
CALL
Atara Biotherapeutics
ATRA
$81.2M
$514K ﹤0.01%
1,412
+468
+50% +$118K
CLVT icon
6844
PUT
Clarivate
CLVT
$1.23B
$514K ﹤0.01%
23,000
+8,300
+56% +$187K
MFIC icon
6845
PUT
MidCap Financial Investment
MFIC
$803M
$514K ﹤0.01%
53,700
+15,100
+39% +$136K
CZR
6846
PUT
DELISTED
Caesars Entertainment Corporation
CZR
$514K ﹤0.01%
42,400
-49,800
-54% -$503K
AZTA icon
6847
CALL
Azenta
AZTA
$1.46B
$513K ﹤0.01%
11,600
-6,800
-37% -$260K
EBND icon
6848
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
$513K ﹤0.01%
+19,565
New +$500K
JOE icon
6849
CALL
St. Joe Company
JOE
$3.89B
$513K ﹤0.01%
26,400
+7,400
+39% +$136K
OCSL icon
6850
Oaktree Specialty Lending
OCSL
$1.14B
$513K ﹤0.01%
+38,260
New +$476K
272 273
274
275 276

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2020 Portfolio in Review

As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.

  • Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
  • Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.